New study reveals impact of 'Long Covid'

A new insight into the longer-term impacts and recovery time for patients hospitalised with Covid-19 has been revealed in a UK-based study.

Report: Mark Nicholls

Recovery duration, co-morbidities, mortality, risk groups: A large study across multiple UK centres reports in detail on prospectively assessed outcomes of Covid-19, the so called 'Long Covid'. We spoke with two of the study's co-investigators about why so many patients are still affected after a coronavirus infection.

Continue reading on HiE+

Sign in

Please enter your login data.

Forgot Password?


Get your free healthcare-in-europe Plus Logo-account now:

Create account

Related articles


In addition to AstraZeneca and Pfizer

Alternating vaccines trial expands to include Moderna and Novavax

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, announce that the programme will be extended to…


After overcoming a Corona infection

Covid-19: Study on long-term antibody protection

Does overcoming a SARS-CoV-2 infection protect against reinfection? The “Rhineland Study”, a population-based study conducted by DZNE in the Bonn area, is now providing new findings in this…


Study hints at increased risk

Many Covid-19 patients return to hospital within 140 days

People discharged from hospital after Covid-19 appear to have increased risks of diseases across multiple organs and nearly a third are readmitted to hospital in the following months, according to a…

Related products

Subscribe to Newsletter